Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.

Biotechnology

Vedere Bio

Cyrus D. Mozayeni

Karen Guerin

Xiaozhi Ren (任小峙) Ph.D.

Soraya Bekkali, MD

Ellen Zyrkowski

Gina Consylman

Martina Schinke

Mark Gaffney

Daniel Zimmer

Mike Murtagh

The executive team at Vedere Bio has experience in gene therapy, pre-clinical development, and clinical development. They have also worked at companies such as BioMarin Pharmaceutical Inc., bluebirdbio Inc., AGTC, and Sangamo BioSciences. They have also been educated at the University of Szeged in Hungary in Genetics and Biochemistry.

CEO and Executive Team

Leadership Team

Founding Team

CEO and Executive Team

About

Team members

Other teams at Vedere Bio

Leadership Team

Founding Team